These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 22681249)
1. Functional selectivity in GPCR heterocomplexes. González-Maeso J; Sealfon SC Mini Rev Med Chem; 2012 Aug; 12(9):851-5. PubMed ID: 22681249 [TBL] [Abstract][Full Text] [Related]
2. Functional selectivity in GPCR signaling: understanding the full spectrum of receptor conformations. Goupil E; Laporte SA; Hébert TE Mini Rev Med Chem; 2012 Aug; 12(9):817-30. PubMed ID: 22681252 [TBL] [Abstract][Full Text] [Related]
3. Functional signaling biases in G protein-coupled receptors: Game Theory and receptor dynamics. Maudsley S; Patel SA; Park SS; Luttrell LM; Martin B Mini Rev Med Chem; 2012 Aug; 12(9):831-40. PubMed ID: 22681251 [TBL] [Abstract][Full Text] [Related]
4. Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential. Seyedabadi M; Ghahremani MH; Albert PR Pharmacol Ther; 2019 Aug; 200():148-178. PubMed ID: 31075355 [TBL] [Abstract][Full Text] [Related]
5. Exploring a role for heteromerization in GPCR signalling specificity. Rozenfeld R; Devi LA Biochem J; 2011 Jan; 433(1):11-8. PubMed ID: 21158738 [TBL] [Abstract][Full Text] [Related]
6. Adhesion G protein-coupled receptors: signaling, pharmacology, and mechanisms of activation. Paavola KJ; Hall RA Mol Pharmacol; 2012 Nov; 82(5):777-83. PubMed ID: 22821233 [TBL] [Abstract][Full Text] [Related]
7. Inverse agonism: the classic concept of GPCRs revisited [Review]. Sato J; Makita N; Iiri T Endocr J; 2016 Jun; 63(6):507-14. PubMed ID: 26961122 [TBL] [Abstract][Full Text] [Related]
13. G-protein-coupled receptor heteromers or how neurons can display differently flavoured patterns in response to the same neurotransmitter. Franco R Br J Pharmacol; 2009 Sep; 158(1):23-31. PubMed ID: 19422387 [TBL] [Abstract][Full Text] [Related]
14. RGS proteins destroy spare receptors: Effects of GPCR-interacting proteins and signal deamplification on measurements of GPCR agonist potency. Chidiac P Methods; 2016 Jan; 92():87-93. PubMed ID: 26297537 [TBL] [Abstract][Full Text] [Related]
15. Versatility of GPCR recognition by drugs: from biological implications to therapeutic relevance. Bosier B; Hermans E Trends Pharmacol Sci; 2007 Aug; 28(8):438-46. PubMed ID: 17629964 [TBL] [Abstract][Full Text] [Related]
16. How ligands and signalling proteins affect G-protein-coupled receptors' conformational landscape. Mary S; Fehrentz JA; Damian M; Verdié P; Martinez J; Marie J; Banères JL Biochem Soc Trans; 2013 Feb; 41(1):144-7. PubMed ID: 23356274 [TBL] [Abstract][Full Text] [Related]
17. Ligand- and heterodimer-directed signaling of the CB(1) cannabinoid receptor. Hudson BD; Hébert TE; Kelly ME Mol Pharmacol; 2010 Jan; 77(1):1-9. PubMed ID: 19837905 [TBL] [Abstract][Full Text] [Related]
18. Biased agonism at G protein-coupled receptors: the promise and the challenges--a medicinal chemistry perspective. Shonberg J; Lopez L; Scammells PJ; Christopoulos A; Capuano B; Lane JR Med Res Rev; 2014 Nov; 34(6):1286-330. PubMed ID: 24796277 [TBL] [Abstract][Full Text] [Related]
20. Analysis of functional selectivity through G protein-dependent and -independent signaling pathways at the adrenergic α(2C) receptor. Kurko D; Kapui Z; Nagy J; Lendvai B; Kolok S Brain Res Bull; 2014 Aug; 107():89-101. PubMed ID: 25080296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]